IL107122A - Pharmaceutical preparations based on 3 thianyl carbonyl 2 or xindole-1-carboxamides - Google Patents

Pharmaceutical preparations based on 3 thianyl carbonyl 2 or xindole-1-carboxamides

Info

Publication number
IL107122A
IL107122A IL10712293A IL10712293A IL107122A IL 107122 A IL107122 A IL 107122A IL 10712293 A IL10712293 A IL 10712293A IL 10712293 A IL10712293 A IL 10712293A IL 107122 A IL107122 A IL 107122A
Authority
IL
Israel
Prior art keywords
pharmaceutical preparation
chloro
weight
formula
compound
Prior art date
Application number
IL10712293A
Other languages
English (en)
Hebrew (he)
Other versions
IL107122A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL107122A0 publication Critical patent/IL107122A0/xx
Publication of IL107122A publication Critical patent/IL107122A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
IL10712293A 1992-10-07 1993-09-27 Pharmaceutical preparations based on 3 thianyl carbonyl 2 or xindole-1-carboxamides IL107122A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07

Publications (2)

Publication Number Publication Date
IL107122A0 IL107122A0 (en) 1993-12-28
IL107122A true IL107122A (en) 1998-08-16

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10712293A IL107122A (en) 1992-10-07 1993-09-27 Pharmaceutical preparations based on 3 thianyl carbonyl 2 or xindole-1-carboxamides

Country Status (21)

Country Link
EP (1) EP0662831A1 (ko)
JP (1) JP2721042B2 (ko)
KR (1) KR950703338A (ko)
CN (1) CN1089138A (ko)
AU (1) AU676200B2 (ko)
BR (1) BR9307182A (ko)
CA (1) CA2146448A1 (ko)
CZ (1) CZ282702B6 (ko)
EG (1) EG20289A (ko)
FI (1) FI934387A (ko)
HU (1) HUT68533A (ko)
IL (1) IL107122A (ko)
MX (1) MX9306222A (ko)
MY (1) MY109680A (ko)
NO (1) NO951350L (ko)
NZ (1) NZ256164A (ko)
PL (1) PL174170B1 (ko)
RU (1) RU2119353C1 (ko)
TW (1) TW438798B (ko)
WO (1) WO1994007488A1 (ko)
ZA (1) ZA937405B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (es) * 1993-08-26 1996-06-16 Pfizer Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
UA42739C2 (uk) * 1995-04-24 2001-11-15 Пфайзер Інк. Спосіб інгібування фоторозкладу фармацевтично активних сполук, таблетка та капсула, що їх містять
AU5340298A (en) * 1996-12-27 1998-07-31 Takeda Chemical Industries Ltd. Stabilized tricyclic compound
JP5869764B2 (ja) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 カプセル充填用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
DE69216642T2 (de) * 1992-01-13 1997-05-07 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit

Also Published As

Publication number Publication date
NO951350L (no) 1995-06-06
FI934387A (fi) 1994-04-08
EP0662831A1 (en) 1995-07-19
EG20289A (en) 1998-07-30
TW438798B (en) 2001-06-07
PL174170B1 (pl) 1998-06-30
AU4839293A (en) 1994-04-26
HUT68533A (en) 1995-04-27
CZ282702B6 (cs) 1997-09-17
MX9306222A (es) 1994-04-29
WO1994007488A1 (en) 1994-04-14
KR950703338A (ko) 1995-09-20
HU9302821D0 (en) 1993-12-28
NZ256164A (en) 1997-03-24
CA2146448A1 (en) 1994-04-14
PL308307A1 (en) 1995-07-24
FI934387A0 (fi) 1993-10-06
ZA937405B (en) 1995-04-06
CZ87895A3 (en) 1995-10-18
BR9307182A (pt) 1999-03-30
NO951350D0 (no) 1995-04-06
IL107122A0 (en) 1993-12-28
CN1089138A (zh) 1994-07-13
MY109680A (en) 1997-04-30
AU676200B2 (en) 1997-03-06
RU2119353C1 (ru) 1998-09-27
JPH07507809A (ja) 1995-08-31
JP2721042B2 (ja) 1998-03-04

Similar Documents

Publication Publication Date Title
EP0948332B1 (en) Antiherpetic medicated stick containing acyclovir for topical application
RU2128505C1 (ru) Фармацевтическая композиция с липидной системой
RU2238083C2 (ru) Лечение хронической экземы кожи рук
US4983626A (en) Anti-rheumatic agents and their use
JP4209467B2 (ja) 経口投与用製剤組成物
EP0357030B1 (en) Use of thromboxane A2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries
ITMI950529A1 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
RU2000107124A (ru) Лечение опосредуемых клеткой иммунных болезней
US5795902A (en) 3-substituted 2-oxindole-1 carboxamide pharmaceutical compositions
IL107122A (en) Pharmaceutical preparations based on 3 thianyl carbonyl 2 or xindole-1-carboxamides
EP0388125A1 (en) Medicament
KR100475388B1 (ko) 1,2,4-벤조트리아진옥사이드의경구겔캡슐제제
BG103917A (bg) Разтворими дозирани форми от сертралин включени вжелатинови капсули
US6528539B1 (en) Stable formulation containing fumagillin
US9731021B2 (en) Hydrogel composition for the treatment of dermatological disorders
JPH044300B2 (ko)
JPH0368009B2 (ko)
JPS631923B2 (ko)
JPH0390022A (ja) 皮膚疾患治療用外用剤
EP0339176A1 (en) Suppository containing a non-steroidal anti-inflammatory medicament
RU92014370A (ru) Препарат для лечения тяжелых кожных заболеваний на основе 13-цис-ретиноевой кислоты
WO2002009670A1 (en) Liquid or semi-solid pharmaceutical excipient and pharmaceutical composition comprising the same
JPH07267875A (ja) オーレオバシジン類の高濃度溶液製剤
IT8922279A1 (it) Formulazioni farmaceutiche per uso topico a base di piridinolcarbammato e suoi polimeri instabili
JPH01216921A (ja) 抗炎症剤

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void